Association of Rituximab Treatment With Disability Progression Among Patients With Secondary Progressive Multiple Sclerosis

IMPORTANCE: Therapeutic options for patients with secondary progressive multiple sclerosis (SPMS) are limited. OBJECTIVE: To analyze disability progression in patients with SPMS treated with rituximab compared with matched control patients never treated with rituximab. DESIGN, SETTING, AND PARTICIPA...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Neurol
Main Authors: Naegelin, Yvonne, Naegelin, Peter, von Felten, Stefanie, Lorscheider, Johannes, Sonder, Judith, Uitdehaag, Bernard M. J., Scotti, Barbara, Zecca, Chiara, Gobbi, Claudio, Kappos, Ludwig, Derfuss, Tobias
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2019
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6439730/
https://ncbi.nlm.nih.gov/pubmed/30615019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2018.4239
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados